Quidel Corporation to Buy Diagnostic Hybrids for $130 Million
Quidel Corp announces the signing of a definitive agreement to acquire privately held Diagnostic Hybrids, Inc. for approximately $130 million in cash.
Read MoreSearch Results for: infectious diseases
TB Diagnostic Based on Digital Imagery Analysis Excels in Clinical Trial
Guardian Technologies International introduces Signature Mapping TBDx (TBDx), an automated diagnostic solution using sophisticated detection algorithms to identify TB under microscopy in sputum samples, at the laboratory level.
Read MoreFDA Approves First Anti-HIV 1+2 Assay for Integrated Diagnostic System
Ortho Clinical Diagnostics announces FDA approval of a diagnostic assay for the detection of antibodies to human immunodeficiency virus (HIV) types 1+2 (Anti-HIV 1+2) for use on the VITROS 5600 Integrated and VITROS 3600 Immunodiagnostic Systems.
Read More
From Pathogen Protection to Ergonomics
Workplace Safety Remains Imperative
Read MoreMultiGEN Diagnostics Launches DNA Sequencing Technology
San Diego-based MultiGEN Diagnostics Inc. has launched a novel multi-target DNA sequencing technology (MultiGEN) for a wide range of clinical testing in molecular diagnostics.
Read More